Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Sugawara, Shunichi, Kondo, Masashi, Yokoyama, Toshihide, Kumagai, Toru, Nishio, Makoto, Goto, Koichi, Nakagawa, Kazuhiko, Seto, Takashi, Yamamoto, Nobuyuki, Kudou, Kentarou, Asato, Takayuki, Zhang, Pingkuan, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700611/
https://www.ncbi.nlm.nih.gov/pubmed/36243793
http://dx.doi.org/10.1007/s10147-022-02252-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700611/
https://www.ncbi.nlm.nih.gov/pubmed/36243793
http://dx.doi.org/10.1007/s10147-022-02252-3

Ejemplares similares